From strategy to execution to delivery
We’re delivering an integrated campaign for INNOVO®
The 2016 launch of the INNOVO® brand and ecommerce site has led to success in both the B2B and B2C markets in the UK, France and Germany. Bray Leino Yucca helped drive this success by delivering the launch strategy, brand design, web design and build, and digital marketing. A recent €15 million funding has enabled Atlantic Therapeutics to further grow the INNOVO® brand, tackling bladder weakness that affects millions worldwide.
This year sees a multi-channel distribution plan for the INNOVO® product to pharmacies, and online with Amazon, across the UK and in Europe.
A BluePrint mapping session with Bray Leino Yucca has helped drive the communications strategy for INNOVO®. eCRM, DRTV and programmatic channels have all been identified as starting points to enhance the customer experience. Bray Leino Yucca are undertaking creative development, production and media buying.
Steve Atkinson, CEO of Atlantic Therapeutics who developed INNOVO®, says: Following last year’s thrilling success of the INNOVO® launch, we are excited to be investing in the customer experience journey with Bray Leino Yucca.
Alan Thorpe, MD of Bray Leino Yucca, says: We look forward to continuing our close partnership with Steve and his team, taking the INNOVO® brand forward to meet the needs of the millions of men and women in Europe who suffer from pelvic floor weakness.